Resilience Training for Age-related Cognitive Decline
(MEDEX-2 Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of this treatment for age-related cognitive decline?
Research shows that Mindfulness-Based Stress Reduction (MBSR) and exercise programs can improve health and well-being, and they have been effective in reducing anxiety and depression in cancer patients. These components may also help with age-related cognitive decline by promoting mental and physical health.12345
Is Mindfulness-Based Stress Reduction (MBSR) safe for humans?
Mindfulness-Based Stress Reduction (MBSR) is generally considered safe for humans and has been used to help with stress, anxiety, depression, and various chronic illnesses. It is a meditation program that has been adapted for different settings, including healthcare staff, and is recommended for its mental health benefits.15678
How does the Resilience Training for Age-related Cognitive Decline treatment differ from other treatments for cognitive decline?
This treatment is unique because it combines physical exercise, health education, and mindfulness-based stress reduction, which together may enhance both physical and cognitive resilience in older adults. Unlike standard treatments that might focus on medication or single interventions, this approach integrates multiple activities to potentially improve overall brain health and delay cognitive decline.910111213
What is the purpose of this trial?
This project capitalizes on a natural experiment imposed by the COVID-19 pandemic in conjunction with an extensive set of cognitive, emotional, biological, and neuroimaging variables already collected at multiple time points in older adults participating in a clinical trial of exercise and mindfulness. This project will elucidate the effects of stress on cognitive function and emotional health in later life, including biological measures of Alzheimer Disease risk, stress, and aging, with the ultimate goal of discovering how to mitigate these effects, among older adults who have made and maintained a lifestyle change.
Research Team
Eric Lenze, MD
Principal Investigator
Washington University School of Medicine
Eligibility Criteria
This trial is for older adults who were part of a previous study (Protocol ID #201410093). They should be able to safely continue with classes and assessments. The focus is on those experiencing cognitive decline or stress related to the COVID-19 pandemic.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in exercise, health education, and mindfulness-based stress reduction activities, with monthly sessions and at-home practice
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exercise
- Health Education
- Mindfulness-Based Stress Reduction
- Mindfulness-Based Stress Reduction + Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator
University of California, San Diego
Collaborator